IAM Patent 1000 2018

Haley Guiliano was recognized among the top patent professionals of 2018 by IAM Patent 1000. Read more here.

Other Recommended Experts

Dechert’s Samuel Abrams has been building life sciences patent portfolios for decades. He is particularly adept at obtaining second-generation patents that allow clients to extend the life of their various franchises. At Cadwalader Wickersham & Taft, Dorothy Auth prosecutes, licenses and litigates patents. She has a PhD in biochemistry and addresses biotech and pharmaceutical questions thoroughly and accurately. Karen Bromberg captains the IP and technology group of Cohen & Gresser, and heads its Israel desk too. She litigates tenaciously and has engaged on some crucial matters lately; acting for AIP Acquisition against Cisco Systems, she argued at the Court of Appeals for the Federal Circuit over the use of a patent’s specification for claim construction purposes, the result of which could clarify the Federal Circuit’s Phillips v AWH decision establishing the hierarchy of evidentiary sources to be used in claim construction. “Latham & Watkins lawyers are smart, diligent and have excellent litigation judgement – Daniel Brown is a good example of that.” The New York partner litigates chemical and life sciences cases with poise and panache, and is hailed for his superlative Hatch-Waxman Act expertise. Flying the flag of Fenwick & West in New York, Daniel Brownstone is making waves by representing a number of technology disruptors. His practice is broad but he is best known for his savvy as a strategic counsellor. Locke Lord’s IP collective has litigation experience in abundance and knows how to bring about commercially desirable results cost effectively. One of its most seasoned advocates – and the chair of the group – is Alan Clement, who continues to meet with immense success litigating under the Hatch-Waxman Act for clients such as Roxane Laboratories. Ivor Elrifi helms the Cooley patent counselling and prosecution group and has been working hard to elevate the firm’s life sciences reputation out on the East Coast. He applies his rigorously commercial mind set to prosecution, licensing and litigation tasks. Leading the charge at Venable’s New York IP group, Frank Gasparo is as comfortable advising the C-suite on strategy as he is advocating in court. Among his recent successes, he obtained a Federal Circuit affirmance of an inter partes review win in which he invalidated various media delivery patents. “Daniel Glazer is a practical guy who cuts to the chase and efficiently realises his clients’ commercial objectives.” A corporate partner at Wilson Sonsini Goodrich & Rosati, he maintains a specialist practice advising foreign companies on US expansion.

A fresh name on the New York landscape, Haley Guiliano is a prosecution and rights management boutique established by former Ropes & Gray partners Joseph Guiliano and James Haley. A trusted confidant of business executives and kin of inventors, Guiliano sews up quality IP protection efficiently. A veteran IP protector, Haley has been a rock for biotech and pharmaceutical clients for over 40 years and, in an evolving market, his worldly wisdom is being relied on more and more.

“Flexible and creative, and someone who can meet tight budgets while doing a quality job”, Philip Hirschhorn is a good guy to have fighting your corner. The experienced litigator co-chairs Buchanan Ingersoll & Rooney’s IP section. Pryor Cashman’s Jeffrey Johnson has the magic touch when it comes to IP value creation and has an encyclopaedia of commercialisation plans for all types of intellectual property. His industry knowledge in telecoms, software, entertainment and life sciences is on point too. Gene Lee can step into any adversarial scenario, exude calm, and come up with solutions that align with the business interests of his clients, including many marquee US and Asian companies. He contributes much to Perkins Coie’s win rate in PTAB trials. Lori Lesser heads Simpson Thacher & Bartlett’s IP transactions group, chairs its privacy and cybersecurity practice and serves as a partner in the litigation department. She is well-versed in all aspects of intellectual property but earns her perennial IAM Patent 1000 inclusion as a leading deal maker. For pharmaceutical companies seeking to procure quality patents and maximise their potential Karen Mangasarian is a cogent choice. The Foley & Lardner partner and former academic research scientist also adds value with her expertise in contentious administrative proceedings. Perkins Coie has one of the country’s most robust all-around patent prosecution and litigation practices. One of the ways in which it has grown stronger of late is through expansion in New York, which is ongoing. Litigator William McCabe is one the local anchors and a touchpoint for a raft of international clients, including many from Japan. “Thomas Meloro is unusual as he maintains excellent relations with both pharmaceutical innovators and generics. He is a superb patent attorney – thoughtful, thorough, believable, upfront, experienced and exceptionally bright.” The life sciences and tech-focused lawyer calls Willkie Farr & Gallagher home. Lucas & Mercanti has an “experienced and committed patent team which is very easy to work with”. Overseeing this is Michael Mercanti, a life sciences wizard with exceptionally strong technical foundations as well as a commercially attuned mind set. He is at his best analysing competitive marketplaces and making chess moves for his clients. Deepro Mukerjee recently made the switch from Alston & Bird to Katten. He’s an experienced Hatch-Waxman litigator who also has in-depth expertise regarding biotechnological processes. David Radulescu runs an eponymous patent litigation boutique that is set up to handle mission-critical, multi-patent and multi-jurisdictional lawsuits. The former Quinn Emanuel partner has a flair for high-tech litigation and has the distinction of being the top expert on cases concerning LEDs. A lead trial lawyer with a wealth of experience, Brian Slater chairs the life sciences practice at Kramer Levin Naftalis & Frankel. He is abreast of all developments in litigation under the Biologics Price Competition and Innovation Act. Deborah Somerville is an accomplished patent attorney who tailors her advice around the specific commercial needs of each client. In so doing, she exhibits impressive range, as she acts for emerging and established companies across the biotech, pharmaceutical and medical device fields. The Fox Rothschild partner also shows dexterity and tact in disputes. Susman Godfrey is a force to be reckoned with in patent litigation and is well known for its efficacy at trial and contingency fee billing model. Arun Subramanian is the set’s head honcho in New York and he makes his first appearance in the IAM Patent 1000 for 2018. A confident leader of senior trial teams, he has set benchmarks and won one of the first cases to uphold a software patent under Alice. Cohen & Gresser’s IP litigation horizons are broadening; it has developed a taste for appellate success and is better positioned to handle cases going up to the Federal Circuit. Francisco Villegas acted with Karen Bromberg to brief an appeal for AIP Acquisition concerning evidentiary sources usable for claim construction. Charles Weiss is an outstanding lawyer. He focuses on intellectual property, particularly patents, but what sets him apart from others is his ability to cross boundaries and advise on other legal issues that affect his clients’ business goals. “He is appropriately guarded in offering advice on what he recognises as a ‘business issue’, but at the same time does not hesitate to do so where he feels he has value to add, or when he feels the client might be missing something. Some lawyers either do not offer such advice, cannot do so meaningfully or are so enamoured with business they lose focus on the legal issues – Charles strikes the perfect balance. Similarly, in litigation, he is aggressive when he needs to be, but always reasonable. When it makes sense to concede a point, he does so in such a way that it cannot be seen as a sign of weakness. In court, he makes a very effective advocate and is clear, credible and to the point.” The Holland & Knight partner is somewhat of a celebrity among dynamic innovators in the pharmaceutical, chemical and biotech areas. Drew Wintringham litigates across the IP spectrum but has a particular faculty for disputes revolving around advanced technologies. The DLA Piper partner also has a vibrant e-commerce practice.